New Deal
Michael Mahoney
Chairman and CEO at BOSTON SCIENTIFIC CORPORATION
Manager
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (9)
Key Relationships
Announcement Date
Deal Value
Btg
Boston Scientific Corporation
£3,029m
64 dealmakers
Preventice Solutions
£896m
54 dealmakers
LUMENIS
£769m
53 dealmakers
Boston Scientific (intrauterine Health Product Portfolio)
Minerva Surgical
value n/a
3 dealmakers
Baylis Medical Company
£1,292m
36 dealmakers
M.I.TECH
£188m
5 dealmakers
OBSIDIO
6 dealmakers
Acotec Scientific Holdings
£426m
14 dealmakers
Axonics Modulation Technologies
£2,672m
13 dealmakers